Background: Based on the fact that site-specific amino acid replacement on peptide antigens stimulated T cell clones to produce increased amount of IFN-γ, we investigated this structure-function relationship, using various peptide analogues Methods: We used three human Th0 clones (BC20.7,BC33.5 and BC42.1) that express distinct TCRα and TCRβ chains, but recognize the same TCR ligand ; i.e., the same framework of peptide antigen BCGa p84-100 in the context of DRB1 * 1405. These T cells were stimulated with various peptide analogues, followed by determination of proliferative responses and IFN-γ production Results: Replacement of Leu at peptide position 2 (P2) by amino acids which are less hydrophobic than the wild type (Val, Ala) or those with similar structural or neutral charge (Thr, Ser), induced increased IFN-γ production from T cells. This phenomenon was associated with structural features of TCR, especially the length of CDR3 region of TCRα. Amino acid replacement at the other positions did not induce increased IFN-γ production Conclusions: Amino acid substitution at P2 frequently induces increased IFN-γ production in a clone-specific manner, which is associated with the structure of CDR3 in TCRVα chains KEY WORDS analogue peptide, complementarity determining region 3, interferon gamma, peptide antigens, T-cell antigen receptor 7. Stern LJ, Brown JH, Jardetzky TS et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 1994;368:215-221. 8. Matsushita S, Yokomizo H, Kohsaka H, Nishimura Y. Diversity of a human CD4 + T cell repertoire recognizing one TCR ligand. Immunol. Lett. 1996;51:191. 9. Kohsaka H, Taniguchi A, Chen PP, Ollier WER, Carson DA. The expressed T cell receptor V gene repertoire of rheumatoid arthritis monozygotic twins : rapid analysis by anchored polymerase chain reaction and enzymelinked immunosorbent assay.
INTRODUCTION
Recent studies showed that T cell activation is not an all-or-none type of event ; rather, qualitative changes in T cell responses can be induced by amino acid substitutions by either MHC molecules or antigenic peptides, i.e., TCR ligands. Flexibility in recognition results in T-cell activation in the absence of a proliferative response, which is designated by the following terminology as demonstrated in previous studies by our group and others : partial agonism, 1 TCR antagonism , 2 anergy , 3 survival 4 and cytokine-specific upregulation. 5, 6 Amino acid residues on antigenic peptides have been roughly divided into two groups ; one that is important for binding to TCR (T cell epitope), and the other that is important for binding to MHC (MHC anchor). However, the crystal structure of the human class II HLA-DR1 complexed with the influenza peptide reported by Stern et al. 7 demonstrated that all the amino acid residues of the influenza virus peptide physically made contact with both HLA and TCR , with the exception of only one residue at the amino terminus which is buried deeply in the groove of class II, hence, there is no possibility for interaction with TCR.
T a b l e 1 A p a n e l o f l a b e l e d T CRA V -s p e c i f i c o l i g o n u c l e ot i d e p r o b e s p o o l s e q u e n c e A V g e n e A T GCT A A GA CCA CA / CCA GCC A V 4 , 2 0
A T CT T CA GA GGGA GCT GT G A V 1 1 In our previous studies, single amino acid substitutions on a group I allergen in the Cryptomeria japonica -derived peptide resulted in a significant increase in IFN-γ production , with no remarkable changes either in proliferative response or IL-4 production. 5 In this study, by using various analogue peptide species, we stimulated three human Th0 clones that express distinct TCRα and TCRβ chains, but recognize the same TCR ligand , and tried to determine the structure-function relationship that leads to increased IFN-γ production from T cells
METHODS

SYNTHESIS OF PEPTIDES
The wild-type BCGa p 84-100 ( EEYLILSARD-VLAVVSK) and its analogue were synthesized using a solid-phase simultaneous multiple peptide synthesizer PSSM-8 (Shimadzu Corp., Kyoto, Japan), and were purified by C 18 reverse-phase HPLC ( Millipore)
T CELL CLONES
BCGa p84-100-specific T cell lines were established as described. 8 Three human CD4 + T cell clones (BC 20.7,BC33.5 and BC42.1) specific to BCGa p84-100+ DRA! DRB1 * 1405, yet bearing distinct TCRβ (BV13S3 ,BV6S1 and BV5S4, respectively ; ) 8 established from PBMC of a BCG-primed healthy individual as described elsewhere, 4 were used throughout the study. T cells were fed 50 U! ml human rIL-2 and irradiated autologous PBMC prepulsed with the wild-type BCGa p84-100 on a weekly basis
ASSESSMENT OF T-CELL RESPONSES
Antigen-induced proliferation of the T cell clones were assayed by culturing the T cells (3×10 4 ! well) in 96-well flat-bottomed culture plates in the presence of a peptide(s) and irradiated PBMC (1.5×10 5 ! well), using RPMI 1640 medium (Gibco, Grand Island, N.Y.) supplemented with 2 mM L-glutamine, 100 units! ml of penicillin , 100 μg ! ml of streptomycin , and 10% heat-inactivated autologous plasma. For the proliferation assay, cells were cultured for 72 hr in the presence of 1 μCi! well of[ 3 H]thymidine during the final 16 hrs . Culture supernatants collected immediately before the addition of[ 3 H]thymidine were used to determine lymphokine concentrations, using hGM-CSF ELISA kits (R& D systems) and hIFN-γ ELISA kits (Otsuka,Tokyo,Japan)
DETERMINATION OF TCRA GENE USAGE BY T CELL CLONES
To determine TCRVA gene usage of the T cell clones that were cultured with irradiated autologous PBMC, RNA were extracted from the cell mixture, and converted to cDNA. TCRA variable region cDNA were amplified with anchored PCR as described previously for amplification of TCRA variable region cDNA. 9 A primary PCR was followed by two sequential nested PCR. TCRAC-specific primers used for primary PCR, nested PCR, and final PCR were CA4 (5'-CAG AAT CCT TAC TTT GTG AC), CA3 (5 ' -ATC GGT GAA TAG GCA GAC AG), and biotinylated CA5 (5'-CAC T a b l e 2 T CRV A a n d T CRV B u s a g e o f B C c l o n e s
T CRV A a n d V B u s a g e a r e s h o wn , wi t h a mi n o a c i d s e q u e n c e s i n t h e N( D) N r e g i o n .
TGG ATT TAG AGT CTC TC), respectively. A panel of labeled TCRAV-specific oligonucleotide probes (Table 1) were used to study TCRAV gene usage with PCR-ELISA . 10 First , seven pools of the AV-specific probes were hybridized with immobilized PCR products in microplates to find out positive wells. Then, the products were hybridized with individual AV probes in another set of plates to pin-point the AV genes predominantly used by the cDNA. To clone the entire variable region cDNA, cDNA were amplified with CA4 and reamplified with a nested primer, CA2 (5'-ACG CGT CGA CAC TGG ATT TAG AGT CTC TC). The products were subcloned into pBluscript II SK+ (Stratagene, La Jolla), and recombinant clones with the dominant VA gene were selected with dot blot DNA hybridization using corresponding VAspecific oligonucleotides. After sequence determination of these clones, dominant clones were selected as cDNA for the T cell clones
RESULTS
TCRVA AND VB SEQUENCES
TCRVA and VB sequences of three T-cell clones BC 20.7, BC33.5 and BC42.1 are shown in Table 2 . The N (D)N region sequences are shown as one-letter codes for amino acids, between V and J segments in parentheses. As described in our earlier studies, these Tcell clones recognize BCGa p84-100 (EEYLILSARD-VLAVVSK ; with first anchor underlined), in the context of HLA-DRB1 * 1405. 4 It is especially important to note that N(D)N region consists of 8 and 11 residues at TCRVA and VB of BC 20.7 and BC 33.5, respectively, whereas that of BC42.1 consists of 9 and 9 residues, repectively.
STIMULATORY ACTIVITIES OF BCGA P 84-100-DERIVED ANALOG PEPTIDE L87V TO BC20.7
To evaluate the effects of single amino acid substitutions, proliferation and lymphokine production in response to analogue peptides were determined and findings were compared with those seen with the wild-type peptide. Most of the analogue peptides that stimulated BC clones showed a pattern of lymphokine production similar to that for the wild-type peptide (not shown). However, IFN-γ production of BC 20.7 was increased in response to several analogue peptides at high concentration (16 μM), especially peptide L87V in which Leu is replaced by Val at the 87 th residue of the peptide BCGa p 84-100, whereas neither T cell proliferation nor production of other lymphokines, showed any remarkable change ; i.e., only the production of IFN-γ was affected for recognition of the analog peptide L87V. As shown in Figure 1 , to determine whether or not the change of IFN-γ production was due to differences in the HLApeptide or TCR-TCR ligand avidity between L87V and the wild-type peptide, responses of BC20.7 to several different concentrations of L87V were compared with those of the wild-type peptide. In the range of concentrations from 0.016 μM up to 16 μM, IFN-γ production in response to L87V constantly exceeded that of the wild-type peptide. Moreover, the plateau level of L87 V-driven IFN-γ production was significantly higher . Mean IFN-γ production of BC20.7 for L87V increased significantly in comparison to the wild-type, whereas no statistical differences were noted in proliferative responses between R21K and the wild-type at a range of 0.16 μM to 16 μM. The IL-4 production of BC20.7 for each analogue peptide was proportional to the proliferative response to each peptide, at a range of 0.0016 to 16 μM (not shown). In contrast, production of GM-CSF gradually increased, in a dose-dependent manner throughout the range of 0.016 to 16 μM. These data indicate that the plateau responses and proliferation of IFN-γ are not due to saturation of the TCR ligand on the APC surface
STIMULATORY ACTIVITIES OF BCGA P 84-100-DERIVED ANALOGUES TO THREE BC CLONES
All three T-cell clones were stimulated with analogues at 16 μM, with replacements at P 1 ( = 86 Y ) through P9 (=94V). Table 3 summarizes the results, regarding proliferative responses and IFN-γ production. P1 (=86Y) replaced by Ala (A) indicates a peptide species EEALILSARDVLAVVSK. Relative IFN-γ responses are shown, where IFN-γ production was divided by proliferation. P1 replaced by A gave values of 96! 100! 98, indicating that BC20.7,BC33.5 and BC 42.1 exhibited 96%, 100% and 98% responses respectively, as compared with the wild-type. Asterisks indicate peptide species that did not exert full agonistic activity ; i.e., peptide stimulation even at 16 μM did not give a plateau response.
Most of analogues that exhibited full agonistic activity, stimulated IFN-γ production at levels roughly similar to the wild-type peptide, i.e., at around 100%. However, it is important to note that L87T,L87S,L87A, and L87V significantly(p<0.01) induced increased levels of IFN-γ production of BC20.7 and BC33.5, but not of BC 42.1. Such a clone-specific phenomenon was 
DISCUSSION
It is not very easy to identify TCR genes used by T cell clones, since they are usually cultured with irradiated autologous PBMC that includes polyclonal T cells. Random cloning of TCR cDNA derived from the cultured cells is minimally helpful in the identification, unless a large number of clones are examined. This problem was circumvented by the use of PCR-ELISA that was developed for TCRBV use, 9 and established in the present report for TCRVA usage . This technique allowed us to quantitate TCRV gene usage in the cDNA samples, and thus to identify the TCRV gene used by the T cell clones.
Three T-cell clones used in the present study recognize the same TCR ligand, as proven in our previous study. This is based on the fact that these clones recognize BCGa p 84-100( 84 EEYLILSARDVLAVVSK 100 ) in the context of DRB1 * 1405, and react to truncated peptides in a similar fashion. 11 Both BC20.7 and BC33.5 have 8 and 11 residues at N(D)N region of TCRVA and VB, respectively, whereas BC42.1 alone exhibits a different pattern, i.e., 9 residues at N(D)N regions of TCRVA and VB. When peptide antigen is presented by class II MHC molecules, the N-terminal half of antigenic peptide is recognized mainly by CDR 3 of TCRVA , whereas the C-terminal half is recoginized by CDR3 of TCRVB, which corresponds to N(D)N regions. 12 Interestingly, certain amino acid replacements on P2 induced increased IFN-γ production in BC20.7 and BC33.5 but not in BC42.1 cells, whereas those on P 8 exhibited full agonism in BC 42.1 cells alone . It is thus likely that structural features of VACDR3 and VBCDR3 are responsible for specific responses induced by P2 and P8 analogues, respectively. Shuffling of N(D)N sequences between BC 42.1 and BC 20.7, or between BC 42.1 and BC 33.5 is underway to address this point Only L87T,L87S,L87A,and L87V induced IFN-γ enhancement. These arrangements are either smaller hydrophobic (A and V), or structurally similar neutral amino acids (T and S), indicating that close contact between P2 and TCRVA is taking place. Indeed, such a phenomenon is also seen in B-cell somatic hypermuation. 13 Thus, B-cell V region mutation in immunoglobulin heavy chain genes shows higher affinity than the germ-line sequence, usually associated with Gly, Ala, Val, Ser, Thr, or Cys, i.e., small hydrophobic or small neutral residues. Apparently these mutations are not associated with static charges, but can affect either hydrogen bonding, van der Waar's force, or hydrophobic interactions.
In our previous studies using cedar pollen-derived peptides, T to V replacement on P2 also induced IFN- γ enhancement, whereas proliferation remained the same . Therefore , although not generalized , mutual replacement on G, A, V, L, S, or T at P2, tends to induce IFN-γ-specific enhancement. Such observations also have been reported in another study with different peptide species. 14 In this sense, analogue-induced clonal anergy is often observed, especially when residue replacement is made on P7 or P8. 11 Moreover, truncation of the C-terminal moiety of antigenic peptides, in general, exhibit TCR antagonism. 15 In other words, if a rule that applies to altered polyclonal novel responses induced by peptide analogues is established, it will lead us to novel therapeutic interventions using peptide analogues. Our observations on P 2 replacement which is associated with increased IFN-γ production are imperative to furthering our understanding
